Reistone Report Results for SHR0302 in P-II Study to Treat Ulcerative Colitis Published: Feb 5, 2020 | Tags: Reiston, Report, Result, SHR0302, P-II, Study, Treat, Ulcerative Colitis Enzene Receives Marketing […]readmore
Tags : 23andMe
Shots: 23andMe signs a SPAC merger with VGAC for an enterprise value of ~$3.5B, including $509M in cash in trust account and $250M PIPE of common stock at $10.00/share If […]readmore
Shots: 23andMe has out-license its bispecific mAb targeted to block three members of the IL-36 cytokine subfamily & will leverage Almirall’s expertise in medical dermatology & accelerating the development the […]readmore
Shots: MAP Report is a direct-to-consumer genetic test and has received FDA approval for MUTYH-associated polyposis (MAP), a hereditary colorectal cancer syndrome Post-FDA approval for BRCA1/BRCA2 (Selected Variants) Genetic […]readmore
Shots: With this collaboration GSK plans improve target selection to develop “Precision Medicine” with better efficacy and safety To identify specific subgroups population to develop targeted treatments GSK is initially […]readmore